In this issue of Gastroenterology Clinics, guest editor Dr. R. Balfour Sartor brings his considerable expertise to the topic of The Microbiome. Research on the gut microbiome has revealed significant implications for gastrointestinal diseases, with clinical trials resulting in potential treatments for the management of GI diseases and their associated risk factors. Further, understanding the gut microbiome’s role in gastrointestinal health opens avenues for targeted interventions and personalized approaches to disease management. This issue presents the latest research, treatments, and clinical approaches in this key area of gastroenterology.
Current Approaches to Treat and Prevent Recurrence of Clostridioides difficile Optimizing Therapeutic Potential of Fecal Transplant in Inflammatory Bowel Disease Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy Personalized Dietary Approaches to Optimizing Intestinal Microbial Health and Homeostasis Beyond Random Fecal Microbial Transplants: Next Generation Personalized Approaches to Normalize Dysbiotic Microbiota for Treating IBD Microbial Influences on Irritable Bowel Syndrome Understanding Microbial Mediation of the Brain-Gut Axis Phase IV Metabolism: Gut Microbial Metabolism of Common Gastrointestinal Drugs Current Understanding of Optimal Prevention of Helicobacter pylori--Induced Cancer Dysbiotic Microbiota in Necrotizing Enterocolitis: Insights into Pathogenesis, Treatment, and Prevention Microbial Approaches to Treat and Prevent Hepatic Encephalopathy Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-Associated Cirrhosis Optimal Approaches to Treating and Preventing Acute and Chronic Pouchitis by Altering Microbial Profiles
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.